Max India Limited (MAXIND) Fair Value & Analysis
Healthcare · IN · Market cap ₹8.3B
Fair value as of: Jul 3, 2026
From 1 valuation models · updated today
Share price +0.1% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹122.14 – ₹222.82 · fair‑value band ₹15.01 – ₹28.43 · the ₹158.64 price screens above the ₹22.75 fair value. As of Jul 3, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Max India Limited (MAXIND) currently trades at ₹158.64, while our model-based Fair Value estimate is ₹22.75 — implying the stock looks roughly 85.7% overvalued today. We read business quality at 42/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
Over the trailing twelve months, Max India Limited generated revenue of ₹2.1B at a net margin of -57.1%. Revenue grew 67.4% year over year. It earns a return on equity of -31.8%. Net debt stands at ₹191M. Fundamentals as of Jul 3, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.
About the company
Max India Limited provides services related to senior living communities in India. It operates through four segments: Business Investments, Senior Living, Assisted Care, and Others. The company engages in the treasury investments and investment property businesses. It also offers senior living services. In addition, the company caters to the seniors by providing care at home services and care homes facilities, as well as offers Antara AGEasy, which is a new-age holistic direct to consumer platform that helps seniors manage common chronic conditions. Further, it offers daily living/specialized care/memory care services for seniors; and management and consultancy and shared services, as well as MedCare products. Additionally, the company engages in the learning and development activities; construction and leasing of senior living communities; and management of investments activities. The company was formerly known as Advaita Allied Health Services Limited. Max India Limited was …
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Max India Limited reported revenue of ₹1.9B in FY2026 versus ₹1.7B in FY2022, a compound +3.0%/yr. Reported net income was −₹1.2B in FY2026.
Is MAXIND fairly valued? → Check now
Similar stocks
6 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$97.60 | R$115.75 | +19% |
| Fresenius SE FSNUY | $11.27 | $8.25 | -27% |
| Q0F Q0F | 2.76 SGD | 1.28 SGD | -54% |
| 5225 5225 | 8.70 MYR | 2.61 MYR | -70% |
| IHHHF IHHHF | $1.71 | $1.26 | -26% |
| Rede D'Or São Luiz S.A RDOR3 | R$33.83 | R$46.94 | +39% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Max India Limited (MAXIND) undervalued?
What is the fair value of MAXIND?
What is the quality score of MAXIND?
What is the revenue of Max India Limited (MAXIND)?
What is the net profit margin of MAXIND?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.